Back
Vistagen Therapeutics Stock Price Chart
Sell
41
VTGN
Vistagen Therapeutics
Last Price:
4.44
Seasonality Move:
5.29%
7 Day Trial
ALL ACCESS PASS
$
7
- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VTGN is experiencing selling pressure, which indicates risk of future bearish movement.
Vistagen Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.49 | Sell |
20-day SMA: | 4.61 | Sell |
50-day SMA: | 4.64 | Sell |
200-day SMA: | 4.7 | Sell |
8-day EMA: | 4.52 | Sell |
20-day EMA: | 4.6 | Sell |
50-day EMA: | 4.68 | Sell |
200-day EMA: | 4.93 | Sell |
Vistagen Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 42.87 | Sell |
Chaikin Money Flow: | -76924 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.5 - 4.76) | Sell |
Bollinger Bands (100): | (4.43 - 5.21) | Sell |
Vistagen Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Vistagen Therapeutics Stock
Is Vistagen Therapeutics Stock a Buy?
- Vistagen Therapeutics share price is 4.44 while VTGN 8-day simple moving average is 4.49, which is a Sell signal.
- The stock price of VTGN is 4.44 while Vistagen Therapeutics 20-day SMA is 4.61, which makes it a Sell.
- Vistagen Therapeutics 50-day simple moving average is 4.64 while VTGN share price is 4.44, making it a Sell technically.
- VTGN stock price is 4.44 and Vistagen Therapeutics 200-day simple moving average is 4.70, creating a Sell signal.
VTGN Technical Analysis vs Fundamental Analysis
Sell
41
Vistagen Therapeutics (VTGN)
is a Sell
Is Vistagen Therapeutics a Buy or a Sell?
-
Vistagen Therapeutics stock is rated a Sell
The current Vistagen Therapeutics [VTGN] share price is $4.44. The Score for VTGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Vistagen Therapeutics Stock Info
Market Cap:
119.99M
Price in USD:
4.44
Share Volume:
76.92K
Vistagen Therapeutics 52-Week Range
52-Week High:
24.71
52-Week Low:
1.62
Sell
41
Vistagen Therapeutics (VTGN)
is a Sell
Vistagen Therapeutics Share Price Forecast
-
What is the Vistagen Therapeutics stock price today?
The Vistagen Therapeutics stock price is 4.44 USD today. -
Will VTGN stock go up or go down?
Vistagen Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Vistagen Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vistagen Therapeutics is overvalued.
Is Vistagen Therapeutics Stock a Buy?
- Vistagen Therapeutics share price is 4.44 while VTGN 8-day exponential moving average is 4.52, which is a Sell signal.
- The stock price of VTGN is 4.44 while Vistagen Therapeutics 20-day EMA is 4.60, which makes it a Sell.
- Vistagen Therapeutics 50-day exponential moving average is 4.68 while VTGN share price is 4.44, making it a Sell technically.
- VTGN stock price is 4.44 and Vistagen Therapeutics 200-day simple moving average is 4.93, creating a Sell signal.
Fundamental Analysis of Vistagen Therapeutics
Is Vistagen Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.08 per share, an increase this year of $6.85 per share, and a decrease next year of $0.43 per share.
Technical Analysis of Vistagen Therapeutics
Should I short Vistagen Therapeutics stock?
- VTGN Moving Average Covergence Divergence (MACD) indicator is -0.08, suggesting Vistagen Therapeutics is a Sell
- Vistagen Therapeutics Relative Strength Index (RSI) is 42.87, which suggest Vistagen Therapeutics is oversold
- The Bollinger Bands (25) for Vistagen Therapeutics is (4.5 - 4.76), which suggest Vistagen Therapeutics is a Sell
- The Bollinger Bands (100) for Vistagen Therapeutics is (4.43 - 5.21), which suggest Vistagen Therapeutics is a Sell
* Vistagen Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.